Kenvue Inc. (NYSE:KVUE) Raises Dividend to $0.21 Per Share

Kenvue Inc. (NYSE:KVUE) declared a quarterly dividend on Wednesday, July 29th. Investors of record on Wednesday, August 12th will be paid a dividend of 0.21 per share on Wednesday, August 26th. This represents a c) annualized dividend and a yield of 4.2%. The ex-dividend date is Wednesday, August 12th. This is a 1.2% increase from Kenvue’s previous quarterly dividend of $0.21.

Kenvue has a dividend payout ratio of 68.0% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Kenvue to earn $1.23 per share next year, which means the company should continue to be able to cover its $0.83 annual dividend with an expected future payout ratio of 67.5%.

Kenvue Trading Up 0.1%

Shares of NYSE:KVUE opened at $19.77 on Thursday. The company has a current ratio of 0.98, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. Kenvue has a 12-month low of $14.02 and a 12-month high of $22.35. The business has a 50 day moving average of $18.52 and a two-hundred day moving average of $17.98. The company has a market capitalization of $37.97 billion, a PE ratio of 23.26, a PEG ratio of 1.50 and a beta of 0.47.

Kenvue (NYSE:KVUE) last posted its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The firm had revenue of $3.91 billion during the quarter, compared to analyst estimates of $3.84 billion. During the same period in the previous year, the firm earned $0.24 EPS. The business’s quarterly revenue was up 4.5% on a year-over-year basis. As a group, analysts forecast that Kenvue will post 1.16 EPS for the current year.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.